Google Chrome
Safari
Firefox
Edge
Search
News / Jul 23, 2021
Hovione signs the COP26 manifest to stop climate changes
BCSD Portugal, 23 July 2021
Press Release / Sep 19, 2024
Hovione and iBET Announce the Establishment of ViSync® Technologies: A Venture in Cell and Gene Therapy Solutions
Commitment to partnership and joint innovation for cell and gene therapies
Dispersome®
Make your drug soluble with Dispersome® technology. Dispersome® is a solubility enhancement technology that relies on an innovative and naturally occurring excipient to develop amorphous solid dispersions with high drug loading and high bioavailability.
Press Clipping / Apr 06, 2023
Hovione 2023 CDMO Leadership Awards Winner Interview
Outsourced Pharma, April 2023
Press Clipping / Mar 19, 2020
Stepping up to the hand sanitizer shortage
Chemical companies, breweries, and perfumeries take to making and donating a vital commodity in short supply
News / Apr 12, 2021
Guy Villax wins EY Award “Entrepreneur of the Year”
EY Entrepreneur Of The Year is the world's most prestigious business award for entrepreneurs
Press Release / Jan 17, 2023
Hovione is recognized as a Top Employer 2023
This certification is a recognition of Hovione´s resolve to put people first, and a validation that the investment in HR excellence is delivering.
News / Sep 09, 2024
Hovione Commits to Science-Based Targets for Greenhouse Gas (GHG) Emissions
Hovione commitment to setting SBTs in line with the Paris Agreement
Article / Jun 02, 2021
Cleaning Continuous Manufacturing Equipment
Pharmaceutical Technology, 2 Junho 2021